申请人:Yamashita Tokuyuki
公开号:US20120101137A1
公开(公告)日:2012-04-26
The object of the present invention is to provide a compound having a glucokinase-activating effect.
A pharmaceutical composition comprising a compound represented by the general formula (I) or a pharmaceutically acceptable salt thereof as an active ingredient:
wherein
X means a nitrogen atom or CR
6
, wherein R
6
means a hydrogen atom or a halogen atom;
R
1
means a hydrogen atom, a C1-C6 alkyl group, a C1-C6 alkoxy group or a C1-C6 alkylthio group;
R
2
means a hydrogen atom or a fluorine atom;
R
3
means a hydrogen atom or a C1-C6 alkyl group; and
one of R
4
and R
5
means a hydrogen atom or a C1-C6 alkyl group, and the other means a C1-C6 alkylenecarboxylic acid, a C1-C6 alkylsulfonyl group, a C1-C6 alkylcarbonyl group, or CONH
2
.
本发明的目的是提供一种具有激活葡萄糖激酶作用的化合物。一种包含以下通式(I)所表示的化合物或其药学上可接受的盐为活性成分的药物组合物:其中X代表一个氮原子或CR6,其中R6代表氢原子或卤素原子;R1代表氢原子、C1-C6烷基、C1-C6烷氧基或C1-C6烷硫基;R2代表氢原子或氟原子;R3代表氢原子或C1-C6烷基;而R4和R5中的一个代表氢原子或C1-C6烷基,另一个代表C1-C6烷基羧酸、C1-C6烷基磺酰基、C1-C6烷基羰基或CONH2。